PRKAB1
MOLECULAR TARGETprotein kinase AMP-activated non-catalytic subunit beta 1
PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PRKAB1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Adenosine Monophosphate Adenine nucleotide containing | 2.20 | 8 |
| 2 | Proguanil | 1.95 | 6 |
| 3 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1.61 | 4 |
| 4 | Niclosamide | 1.39 | 3 |
| 5 | Berberine | 1.10 | 2 |
| 6 | Ursolic Acid | 1.10 | 2 |
| 7 | Antimycin | 1.10 | 2 |
| 8 | Oleanolic Acid | 1.10 | 2 |
| 9 | Rotenone | 1.10 | 2 |
| 10 | Metformin | 0.69 | 1 |
About PRKAB1 as a Drug Target
PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented PRKAB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PRKAB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.